American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection

作者：Momen M. Wahidi, Carla Lamb, Septimiu Dan Murgu, Ali Imran Musani, Samira Shojaee, Ashutosh Sachdeva, Fabien Maldonado, Kamran Mahmood, Matthew Kinsey, Sonali Sethi, Amit Kumar Mahajan, Adnan Majid, Colleen M. Keyes, Abdul Hamid Alraiyes, Arthur Wai Sung, David W. Hsia, George A. Eapen · 发表于：Journal of Bronchology & Interventional Pulmonology · 年份：2020 · DOI：10.1097/lbr.0000000000000681 · 被引用次数：238 · 研究领域：COVID-19 and healthcare impacts、COVID-19 diagnosis using AI、Ultrasound in Clinical Applications

To the Editor: Considering the global spread of COVID-19 infection and the increased number of confirmed COVID-19 cases across the United States, the American Association for Bronchology and Interventional Pulmonology (AABIP) is issuing this statement on the safe and effective use of bronchoscopy in patients with suspected or confirmed COVID-19 infection. The main purpose of this statement is to ensure the safety of our patients, health care team and community at large. We are releasing these urgent recommendations to guide clinicians around the world with the understanding that new information may subsequently modify or impact these current recommendations. We will strive to update this statement as needed in a timely fashion. This document is based on the latest Centers for Disease Control (CDC) recommendations March 9, 2020 and expert consensus of the AABIP COVID-19 Task Force. General Recommendations for collection of respiratory specimen collection for suspected COVID-191–4: Collection of upper respiratory samples via nasopharyngeal and oropharyngeal swabs is the primary and preferred method for diagnosis. Respiratory specimen collection is recommended in suspected COVID-19 regardless of time of onset of symptoms. Induced sputum collection is NOT recommended. Because it is an aerosol generating procedure that poses substantial risk to patients and staff, bronchoscopy should have an extremely limited role in the diagnosis of COVID-19 and only be considered in intubated pa...